A single injection produced long-term miR871 expression, triggered selective RNA interference against the PMP22 mRNA, and subsequently lowered protein levels and improved disease manifestations in a humanized CMT1A model. The gene discussed is PMP22; the disease is Charcot-Marie-Tooth disease type 1A.